Ch. Scharfetter

Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG)

F. Vollenweider, J. Missimer, K. Leenders, 1997, European Neuropsychopharmacology.

Positron Emission Tomography and Fluorodeoxyglucose Studies of Metabolic Hyperfrontality and Psychopathology in the Psilocybin Model of Psychosis

F. Vollenweider, K. Leenders, J. Angst, 1997, Neuropsychopharmacology.

Ethnicity‐independent genetic basis of functional psychoses: A genotype‐to‐phenotype approach

H. Stassen, D. Hell, M. Weisbrod, 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Schizophrenia and smoking: evidence for a common neurobiological basis?

H. Stassen, M. Weisbrod, C. Scharfetter, 2000, American journal of medical genetics.

Predicting Response to Psychopharmacological Treatment: Survey of Recent Results

D. Rujescu, H. Stassen, A. Szegedi, 2011, Pharmacopsychiatry.

On the prognostic relevance of ego-psychopathology in schizophrenia: A 2.5-year follow-up

C. Scharfetter, R. Hauser, Ch. Scharfetter, 2005, European archives of psychiatry and neurological sciences.